Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Income from Continuing Operations of 15679000.0 for Q1 2026, up 42.39% year-over-year from 11011000.0 in Q1 2025, and down 12.38% quarter-over-quarter from 17894000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Income from Continuing Operations for 17 consecutive years, with 15679000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 42.39% year-over-year to 15679000.0; the TTM figure through Mar 2026 stood at 64714000.0 (up 11.58% YoY), while the FY2025 annual figure was 60046000.0, up 5.58% from the prior year.
- Income from Continuing Operations declined to 15679000.0 in Q1 2026 per LMAT's latest filing, from 17894000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 24021000.0 in Q4 2024 and bottomed at 3515000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 10713235.29 across 5 years, with a median of 9887000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 57.65% — and 2024, when it soared 183.77%.
- Lemaitre Vascular's Income from Continuing Operations stood at 4411000.0 in 2022, then surged by 91.91% to 8465000.0 in 2023, then jumped by 183.77% to 24021000.0 in 2024, then declined by 25.51% to 17894000.0 in 2025, then decreased by 12.38% to 15679000.0 in 2026.
- Business Quant data shows LMAT's Income from Continuing Operations at 15679000.0 in Q1 2026, 17894000.0 in Q4 2025, and 17362000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 17.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.05 Mn |
| Mar 31, 2026 | 15.68 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 17.36 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | 24.02 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 11.83 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 8.10 Mn |
| Mar 31, 2023 | 6.04 Mn |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 6.04 Mn |
| Dec 31, 2021 | 6.04 Mn |
| Sep 30, 2021 | 6.50 Mn |